Olanzapine poisoning in patients treated at the National Poison Control Centre in Belgrade, Serbia in 2017 and 2018: a brief review of serum concentrations and clinical symptoms
, , , , , y
07 jul 2022
Acerca de este artículo
Categoría del artículo: Original article
Publicado en línea: 07 jul 2022
Páginas: 126 - 130
Recibido: 01 feb 2022
Aceptado: 01 may 2022
DOI: https://doi.org/10.2478/aiht-2022-73-3635
Palabras clave
© 2022 Snežana Đorđević, Nataša Perković Vukčević, Marko Antunović, Vesna Kilibarda, Gordana Vuković Ercegović, Jasmina Jović Stošić, and Slavica Vučinić, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Đorđević, Snežana
University of Defence, Military Medical Academy Medical Faculty, National Poison Control CentreBelgrade, Serbia
Vukčević, Nataša Perković
University of Defence, Military Medical Academy Medical Faculty, National Poison Control CentreBelgrade, Serbia
Antunović, Marko
University of Defence, Military Medical Academy Medical Faculty, National Poison Control CentreBelgrade, Serbia
Kilibarda, Vesna
University of Defence, Military Medical Academy Medical Faculty, National Poison Control CentreBelgrade, Serbia
Ercegović, Gordana Vuković
University of Defence, Military Medical Academy Medical Faculty, National Poison Control CentreBelgrade, Serbia
Stošić, Jasmina Jović
University of Defence, Military Medical Academy Medical Faculty, National Poison Control CentreBelgrade, Serbia
Vučinić, Slavica
University of Defence, Military Medical Academy Medical Faculty, National Poison Control CentreBelgrade, Serbia